Sign In
Buy ACCD
$7.02
+0 (+0%)
At Close: Jul 07, 2025
Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates
09:10am, Tuesday, 08'th Oct 2024
Accolade (ACCD) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.43 per share a year ago.
Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30
08:31am, Tuesday, 08'th Oct 2024
On October 8, 2024, Accolade Inc (ACCD, Financial) released its 8-K filing detailing the financial results for the fiscal second quarter ending August 31, 2024. Accolade Inc, a company offering techno
Accolade Announces Results for Fiscal Second Quarter 2025
07:00am, Tuesday, 08'th Oct 2024
SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024.
Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings
08:01am, Monday, 07'th Oct 2024
Accolade Inc (ACCD, Financial) is set to release its Q2 2025 earnings on Oct 8, 2024. The consensus estimate for Q2 2025 revenue is $105.01 million, and the earnings are expected to come in at -$0.44
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings
04:19am, Friday, 04'th Oct 2024
Accolade, Inc. ACCD will release earnings results for its second quarter, before the opening bell on Tuesday, Oct. 8.
Accolade to Announce Fiscal Second Quarter 2025 Financial Results
08:00am, Wednesday, 18'th Sep 2024
SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market o
Tri Pointe Homes Receives 2024 People Companies That Care® Accolade and 2024 Fortune Best Workplaces in Construction™ Distinction
12:00pm, Tuesday, 10'th Sep 2024
The competitive and prestigious awards recognize Tri Pointe Homes for its outstanding commitment to employee well-being and innovative workplace practices year-over-year The competitive and prestigiou
All You Need to Know About Accolade (ACCD) Rating Upgrade to Buy
01:01pm, Friday, 30'th Aug 2024
Accolade (ACCD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD)
07:25am, Thursday, 29'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of
Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference
08:00am, Wednesday, 28'th Aug 2024
SEATTLE, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursd
Accolade, Inc. (ACCD) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
07:25am, Wednesday, 28'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of
Accolade, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ACCD
07:25am, Tuesday, 27'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of
Accolade, Inc. (ACCD) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
07:30am, Monday, 26'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of
Accolade Being Investigated on Behalf of Accolade, Inc. Investors. Contact Levi & Korsinsky For Details.
07:30am, Friday, 23'rd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of
First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies
10:03am, Thursday, 22'nd Aug 2024
LITTLE ROCK, Ark. , Aug. 22, 2024 /PRNewswire/ -- Celeste Health Solutions (Celeste), a new company that will focus on merging the power of data insights, technology and personalized health management
